Cell Harvesting Market - Growth, Trends, and Forecast (2019 - 2024)
|出版商||Mordor Intelligence LLP||商品編碼||907077|
|出版日期||內容資訊||英文 113 Pages
|全球細胞收集市場:成長，趨勢，預測 Cell Harvesting Market - Growth, Trends, and Forecast (2019 - 2024)|
|出版日期: 2019年05月01日||內容資訊: 英文 113 Pages||
The major factors for the growth of the cell harvesting market include the rising investments in regenerative medicine and cell-based research, growth of the biotechnology and biopharmaceutical industries, and increasing incidence of chronic and infectious diseases.
According to the World Health Organization (WHO), chronic diseases are expected to increase by 57% by 2020. Increased demand for healthcare systems due to chronic diseases has become a major concern. The Center for Disease Control and Prevention (CDC), states that in 2017, chronic diseases were the leading cause of death and disability in the United States, and 133 million Americans, i.e., 45% of the population, had at least one chronic disease. In addition, the rise of age and lifestyle-related chronic diseases is increasing the demand and spending for healthcare. In developing markets, cancer and heart disease are becoming the main causes of death as a result of urbanization, sedentary lifestyles, changing diets, rising obesity levels, and widespread availability of tobacco products. The potential use of stem cells in treating various chronic disease is the major factor for the growth of the market. Thus, increasing prevalence of the chronic and infectious disease is expected to spur market growth.
As per the scope of this report, cell harvesting is a technique of collecting cells. Cell harvesting is considered as an important step in the biopharmaceutical manufacturing industry, which is likely to directly affect the product quality and related downstream processes. The market is segmented by type of cell harvesting, application, end-user, and geography.
Human stem cell research holds enormous potential for contributing to the understanding of fundamental human biology. Studying the stem cells are helping scientists to understand more about how the body works and how the disease develops and affects the body. Working on stem cell research is helping researchers to better understand different diseases and conditions, and in finding new treatments. Human stem cell research should be integrated into the mainstream of biomedical research, including disease modeling, the study of cellular degenerative processes, development of pharmaceutical and toxicological screening platforms, and regenerative therapy. As per the data published by the National Institute of Health, around 60,000 patients are treated with bone marrow transplantation (BMT) per year worldwide. The bone marrow-derived stem cells can advance the study of stem cell biology, stem cell-based therapies, and regenerative medicine. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.
North America is found to hold a major share for the cell harvesting market and is expected to show a similar trend over the forecast period, without significant fluctuations. The market in the United States is dominating the cell harvesting market, due to increasing research expenditure and government initiatives. Currently, the only stem cell-based products that are approved by the FDA for use in the United States consist of blood-forming stem cells, derived from cord blood. These, as well as, stem cells, which come from bone marrow, are commonly used in transplant procedures to treat patients with cancer and disorders of the blood and immune system. Furthermore, there is a rise in healthcare spending in the United States. These above-mentioned factors are the key elements that are augmenting the growth of the market and making it stable, in the United States. However, in the United States, a research conducted in 2016 found hundreds of the clinics in the United States selling unapproved stem cell treatments, which is likely to hinder the growth of the market in the United States, which is likely to restraint for market growth.
The market studied is a moderately consolidated market owing to the presence of small and large market players. Some of the market players are Arthrex Inc., AVITA Medical, GE Healthcare, Pall Corporation, Perkin Elmer Inc., Sartorius AG, Terumo Corporation, and Tomtec